The states with the highest rates of HIV diagnoses in 2022 included Georgia, Louisiana, and Florida. However, the states with the highest number of people with HIV were Texas, California, and Florida. In Texas, there were around 4,896 people diagnosed with HIV. HIV/AIDS diagnoses In 2022, there were an estimated 38,043 new HIV diagnoses in the United States, a slight increase compared to the year before. Men account for the majority of these new diagnoses. There are currently around 1.2 million people living with HIV in the United States. Deaths from HIV The death rate from HIV has decreased significantly over the past few decades. In 2023, there were only 1.3 deaths from HIV per 100,000 population, the lowest rate since the epidemic began. However, the death rate varies greatly depending on race or ethnicity, with the death rate from HIV for African Americans reaching 19.2 per 100,000 population in 2022, compared to just three deaths per 100,000 among the white population.

The average for 2022 based on 48 countries was 3.95 percent. The highest value was in Swaziland: 25.9 percent and the lowest value was in Algeria: 0.1 percent. The indicator is available from 1990 to 2022. Below is a chart for all countries where data are available.

Among all countries worldwide those in sub-Saharan Africa have the highest rates of HIV. The countries with the highest rates of HIV include Eswatini, South Africa, and Lesotho. In 2024, Eswatini had the highest prevalence of HIV with a rate of around ** percent. Other countries, such as Zimbabwe, have significantly decreased their HIV prevalence. Community-based HIV services are considered crucial to the prevention and treatment of HIV. HIV Worldwide The human immunodeficiency virus (HIV) is a viral infection that is transmitted via exposure to infected semen, blood, vaginal and anal fluids, and breast milk. HIV destroys the human immune system, rendering the host unable to fight off secondary infections. Globally, the number of people living with HIV has generally increased over the past two decades. However, the number of HIV-related deaths has decreased significantly in recent years. Despite being a serious illness that affects millions of people, medication exists that effectively manages the progression of the virus in the body. These medications are called antiretroviral drugs. HIV Treatment Generally, global access to antiretroviral treatment has increased. However, despite being available worldwide, not all adults have access to antiretroviral drugs. There are many different antiretroviral drugs available on the market. As of 2024, ********, an antiretroviral marketed by Gilead, was the leading HIV treatment based on revenue.

United States US: Prevalence of HIV: Total: % of Population Aged 15-49 data was reported at 0.500 % in 2014. This stayed constant from the previous number of 0.500 % for 2013. United States US: Prevalence of HIV: Total: % of Population Aged 15-49 data is updated yearly, averaging 0.500 % from Dec 2008 (Median) to 2014, with 7 observations. The data reached an all-time high of 0.500 % in 2014 and a record low of 0.500 % in 2014. United States US: Prevalence of HIV: Total: % of Population Aged 15-49 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s USA – Table US.World Bank: Health Statistics. Prevalence of HIV refers to the percentage of people ages 15-49 who are infected with HIV.; ; UNAIDS estimates.; Weighted Average;

In 2024, in South Africa, there were around 3.1 HIV newly infected persons per every 1,000 inhabitants. This statistic depicts the countries with the highest incidence rates of new HIV infections worldwide as of 2024.

Prevalence of HIV, total (% of population ages 15-49) in Romania was reported at 0.1 % in 2022, according to the World Bank collection of development indicators, compiled from officially recognized sources. Romania - Prevalence of HIV, total (% of population ages 15-49) - actual values, historical data, forecasts and projections were sourced from the World Bank on July of 2025.

United Arab Emirates AE: Incidence of HIV: per 1,000 Uninfected Population data was reported at 0.130 Ratio in 2020. This records an increase from the previous number of 0.120 Ratio for 2019. United Arab Emirates AE: Incidence of HIV: per 1,000 Uninfected Population data is updated yearly, averaging 0.020 Ratio from Dec 1990 (Median) to 2020, with 31 observations. The data reached an all-time high of 0.130 Ratio in 2020 and a record low of 0.010 Ratio in 2004. United Arab Emirates AE: Incidence of HIV: per 1,000 Uninfected Population data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s United Arab Emirates – Table AE.World Bank.WDI: Social: Health Statistics. Number of new HIV infections among uninfected populations expressed per 1,000 uninfected population in the year before the period.;UNAIDS estimates.;Weighted average;This is the Sustainable Development Goal indicator 3.3.1 [https://unstats.un.org/sdgs/metadata/].

Prevalence of HIV, total (% of population ages 15-49) in Hungary was reported at 0.1 % in 2018, according to the World Bank collection of development indicators, compiled from officially recognized sources. Hungary - Prevalence of HIV, total (% of population ages 15-49) - actual values, historical data, forecasts and projections were sourced from the World Bank on September of 2025.

People aged 15 to 59 years seen at HIV services in the UK, expressed as a rate per 1,000 population.Data is presented by area of residence, and exclude people diagnosed with HIV in England who are resident in Wales, Scotland, Northern Ireland or abroad.RationaleThe geographical distribution of people seen for HIV care and treatment is not uniform across or within regions in England. Knowledge of local diagnosed HIV prevalence and identification of local risk groups can be used to help direct resources for HIV prevention and treatment.In 2008, http://www.bhiva.org/HIV-testing-guidelines.aspx recommended that Local Authority and NHS bodies consider implementing routine HIV testing for all general medical admissions as well as new registrants in primary care where the diagnosed HIV prevalence exceeds 2 in 1,000 population aged 15 to 59 years.In 2017, guidelines were updated by https://www.nice.org.uk/guidance/NG60 which is co-badged with Public Health England. This guidance continues to define high HIV prevalence local authorities as those with a diagnosed HIV prevalence of between 2 and 5 per 1,000 and extremely high prevalence local authorities as those with a diagnosed HIV prevalence of 5 or more per 1,000 people aged 15 to 59 years.When this is applied to national late HIV diagnosis data, it shows that two-thirds of late HIV diagnoses occur in high-prevalence and extremely-high-prevalence local authorities. This means that if this recommendation is successfully applied in high and extremely-high-prevalence areas, it could potentially affect two-thirds of late diagnoses nationally.Local authorities should find out their diagnosed prevalence published in UKHSA's http://fingertips.phe.org.uk/profile/sexualhealth , as well as that of surrounding areas and adapt their strategy for HIV testing using the national guidelines.Commissioners can use these data to plan and ensure access to comprehensive and specialist local HIV care and treatment for HIV diagnosed individuals according to the http://www.medfash.org.uk/uploads/files/p17abl6hvc4p71ovpkr81ugsh60v.pdf and http://www.bhiva.org/monitoring-guidelines.aspx .Definition of numeratorThe number of people (aged 15 to 59 years) living with a diagnosed HIV infection and accessing HIV care at an NHS service in the UK and who are resident in England.Definition of denominatorResident population aged 15 to 59.The denominators for 2011 to 2023 are taken from the respective 2011 to 2023 Office for National Statistics (ONS) revised population estimates from the 2021 Census.Further details on the ONS census are available from the https://www.ons.gov.uk/census .CaveatsData is presented by geographical area of residence. Where data on residence were unavailable, residence have been assigned to the local health area of care.Every effort is made to ensure accuracy and completeness of the data, including web-based reporting with integrated checks on data quality. The overall data quality is high as the dataset is used for commissioning purposes and for the national allocation of funding. However, responsibility for the accuracy and completeness of data lies with the reporting service.Data is as reported but rely on ‘record linkage’ to integrate data and ‘de-duplication’ to prevent double counting of the same individual. The data may not be representative in areas where residence information is not known for a significant proportion of people accessing HIV care.Data supplied for previous years are updated on an annual basis due to clinic or laboratory resubmissions and improvements to data cleaning. Data may therefore differ from previous publications.Values are benchmarked against set thresholds and categorised into the following groups: <2 (low), 2 to 5 (high) and≥5 (extremely high). These have been determined by developments in national testing guidelines.The data reported in 2020 and 2021 is impacted by the reconfiguration of sexual health services during the national response to COVID-19.

HIV prevalence of Cameroon dropped by 7.14% from 2.8 % in 2021 to 2.6 % in 2022. Since the 2.44% decline in 2012, HIV prevalence plummeted by 35.00% in 2022. Prevalence of HIV refers to the percentage of people ages 15-49 who are infected with HIV.

The Global Burden of Disease Study 2015 (GBD 2015), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors globally, for 21 regions, and for 195 countries and territories. This dataset was also published in The Lancet in July 2016 in "Global, regional, and national incidence, prevalence, and mortality for HIV, 1980-2015: estimates from the Global Burden of Disease Study 2015."

The total number of people globally living with HIV has increased from **** million people in 2000 to **** million people in 2024. However, the total number of new HIV infections has decreased from *** million in 2000 to *** million in 2024. It has become easier for those infected with HIV to live longer lives. Death rates for HIV-positive people are decreasing, mostly due to antiretroviral drugs that have turned the infection into a chronic disease. Nevertheless, those with HIV are at a higher risk for conditions such as liver disease, heart disease, and cancer. Medication for HIV has become more widespread and has made HIV a more manageable condition. However, medicine is not widely accessible in the developing world, and treatment is still lacking. In Eswatini, around ** percent of all people between 15 and 49 years are living with HIV, while the percentage is around ** in South Africa. HIV infections are still especially widespread in Eastern and Southern Africa, with **** million people living with the condition in 2024. In the same year, there were around *** million people in Latin America living with HIV.

Cuba CU: Prevalence of HIV: Total: % of Population Aged 15-49 data was reported at 0.600 % in 2022. This stayed constant from the previous number of 0.600 % for 2021. Cuba CU: Prevalence of HIV: Total: % of Population Aged 15-49 data is updated yearly, averaging 0.200 % from Dec 1990 (Median) to 2022, with 33 observations. The data reached an all-time high of 0.600 % in 2022 and a record low of 0.100 % in 2003. Cuba CU: Prevalence of HIV: Total: % of Population Aged 15-49 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Cuba – Table CU.World Bank.WDI: Social: Health Statistics. Prevalence of HIV refers to the percentage of people ages 15-49 who are infected with HIV.;UNAIDS estimates.;Weighted average;

Data from the individual questionnaires used in the THMIS make it possible to match husbands and wives. In this way, it is possible to tabulate data on the HIV status of couples who weremarried or living together in the same household, so long as both were tested for HIV

This is historical data. The update frequency has been set to "Static Data" and is here for historic value. Updated on 8/14/2024 HIV Incidence Rate - This indicator shows the rate of adult/adolescent cases (age 13+) diagnosed with HIV (per 100,000 population). HIV is a significant and preventable public health problem. An estimated 16% of people with HIV in Maryland are undiagnosed. We have the knowledge and tools needed to slow the spread of HIV infection and improve the health of people living with HIV. Link to Data Details

Prevalence of HIV, total (% of population ages 15-49) in United States was reported at 0.4 % in 2021, according to the World Bank collection of development indicators, compiled from officially recognized sources. United States - Prevalence of HIV, total (% of population ages 15-49) - actual values, historical data, forecasts and projections were sourced from the World Bank on September of 2025.

Much of the information on national HIV prevalence in Tanzania derives from surveillance of HIV in special populations, such as women attending antenatal clinics and blood donors. For example, Mainland Tanzania currently maintains a network of 134 antenatal care (ANC) sites from which HIV prevalence estimates are generated. However, these surveillance data do not provide an estimate of the HIV prevalence among the general population. HIV prevalence is higher among individuals who are employed (6 percent) than among those who are not employed (3 percent) and is higher in urban areas than in rural areas (7percent and 4 percent, respectively). In Mainland Tanzania, HIV prevalence is markedly higher than in Zanzibar (5 percent versus 1 percent). Differentials by region are large. Among regions on the Mainland,Njombe has the highest prevalence estimate (15 percent), followed by Iringa and Mbeya (9 percent each);Manyara and Tanga have the lowest prevalence (2 percent). Among the five regions that comprise Zanzibar, all have HIV prevalence estimates at 1 percent or below. Consistent with the overall national estimate among men and women, HIV prevalence is higher among women than men in nearly all regions of Tanzania.

Users can access population data related to the screening, prevalence, and incidence of HIV and AIDS in the United States. Background The HIV/AIDS Statistics and Surveillance data is maintained by the Centers for Disease Control. Annual reports, fact sheets, slide sets, and basic statistics are available in a variety of formats. Fact sheets are available for a variety of subgroups including but not limited to examining HIV prevalence among different races, ages, and sexual orientations. Slide sets looking at HIV and AIDS prevalence among different groups and different regions are also available. The HIV Surveillance Report is available on an annual basis. User functionality Data is presented in report or fact sheet format and can be downloaded in PDF or HTML formats. Slide sets are available in PDF or PowerPoint format. Basic statistics and other information is avaible in HTML format. Data Notes The data sources are clearly referenced for each report, chart, and fact sheet. The most recent data is from 2009. Reports are published annually in the late summer or early fall

Mexico MX: Prevalence of HIV: Male: % Aged 15-24 data was reported at 0.200 % in 2017. This stayed constant from the previous number of 0.200 % for 2016. Mexico MX: Prevalence of HIV: Male: % Aged 15-24 data is updated yearly, averaging 0.200 % from Dec 1990 (Median) to 2017, with 28 observations. The data reached an all-time high of 0.200 % in 2017 and a record low of 0.100 % in 2009. Mexico MX: Prevalence of HIV: Male: % Aged 15-24 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Mexico – Table MX.World Bank.WDI: Health Statistics. Prevalence of HIV, male is the percentage of males who are infected with HIV. Youth rates are as a percentage of the relevant age group.; ; UNAIDS estimates.; Weighted average; In many developing countries most new infections occur in young adults, with young women being especially vulnerable.